XML 38 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Details Narrative) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended
Oct. 30, 2019
Nov. 09, 2018
Apr. 30, 2019
Oct. 31, 2018
Jul. 31, 2018
May 31, 2018
Mar. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Conversion of Series E Preferred stock for common stock (in shares)       2      
Shares issued upon conversion       20,000      
Warrants outstanding (in shares)             36,272,500
Warrants              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Weighted average exercise price (in dollars per share)             $ 0.56
Warrant              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Warrants outstanding (in shares)             36,272,500
Adjustable warrants, shares             35,580,017
Number of warrants expired             1,189,079
Warrant | Convertible Debt              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Warrants outstanding (in shares)             1,944,250
Series E convertible preferred stock              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Number of unregistered shares issued during period     107,846        
Conversion of Series C Preferred stock for common stock     $ 53,923        
Accrued dividends             $ 2,700,000
Series F Convertible preferred stock              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Accrued dividends             $ 238,000
Stock repurchased during period (in shares) 20            
Accrued and unpaid fees $ 150,000            
Value of stock repurchased during period $ 100,000            
Subscription Agreements | Warrant              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Warrants to purchase shares of common stock (in shares)   0.75          
Exercise price per share (in dollars per share)   $ 0.55       $ 0.55  
Term of warrant   5 years     5 years 5 years  
Subscription Agreements | Warrant | Private Placement              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Warrants to purchase shares of common stock (in shares)   73,000     308,000 2,958,460  
Subscription Agreements | Series E convertible preferred stock              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Sale of stock (in shares)           2,812  
Exercise price per share (in dollars per share)         $ 0.50    
Preferred stock stated dividend rate           8.00%  
Subscription Agreements | Series E convertible preferred stock | Private Placement              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Proceeds from private placement           $ 12,200,000  
Placement agent fees and estimated expenses           2,000,000.0  
Subscription Agreements | Series E convertible preferred stock | Warrant              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Purchase price of preferred stock           $ 5,000  
Common stock at a conversion price (in dollars per share)           $ 0.50  
Term of warrant     5 years        
Warrants to purchase shares of common stock (in shares)           0.75  
Subscription Agreements | Series F Convertible preferred stock              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Sale of stock (in shares)   73     308    
Purchase price of preferred stock   $ 5,000     $ 5,000    
Common stock at a conversion price (in dollars per share)   $ 0.50     $ 0.50    
Term of warrant   5 years     5 years    
Preferred stock stated dividend rate         8.00%    
Term of warrant         5 years    
Proceeds from private placement   $ 300,000     $ 1,400,000    
Placement agent fees and estimated expenses         $ 180,000    
Weighted average exercise price (in dollars per share)   $ 0.55     $ 0.55    
Subscription Agreements | Series F Convertible preferred stock | Warrant              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Warrants to purchase shares of common stock (in shares)         0.75    
Exercise price per share (in dollars per share)         $ 0.55